eGenesis, Inc.

eGenesis, Inc. is at the forefront of biotechnology research, dedicated to developing human-compatible organs for transplantation. With a focus on transforming the future of transplantation, eGenesis is addressing the global organ shortage crisis through innovative solutions. The company's state-of-the-art facilities are located at 300 Technology Sq, Cambridge, MA 02139, US.

eGenesis is revolutionizing the field with an unparalleled, multiplexed gene editing platform designed for the development of human-compatible organs, tissues, and cells. By harnessing the latest gene-editing techniques, eGenesis aims to provide a scalable alternative to allotransplantation. The company is committed to advancing xenotransplantation by overcoming key virology and immunology challenges, paving the way for commercially viable products.

eGenesis is dedicated to saving and improving the lives of patients awaiting organ transplants through groundbreaking research and development. Discover how eGenesis, Inc. is shaping the future of biotechnology. We invite the manager of eGenesis, Inc. to create a customized and exclusive company showcase and product listing on our platform to further enhance its visibility and commercial development.